UK woman pregnant with screened embryo

A British woman has used genetic screening technology to select specific embryos used in IVF to make sure she became pregnant with a child who will not have to face the same risk of genetic eye cancer she was born with. Doctors were able to extract a cell for screening. The process of genetic selection of embryos has spurred controversy around the world from groups opposed to a new generation of "designer" babies. Doctors see it as an effective tool for eliminating abnormal genes that have afflicted families for generations.

- read this article from The Times

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.